162 related articles for article (PubMed ID: 36464749)
21. MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.
Punga AR; Maj M; Lin S; Meinen S; Rüegg MA
Eur J Neurosci; 2011 Mar; 33(5):890-8. PubMed ID: 21255125
[TBL] [Abstract][Full Text] [Related]
22. Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin.
Henriquez JP; Webb A; Bence M; Bildsoe H; Sahores M; Hughes SM; Salinas PC
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18812-7. PubMed ID: 19020093
[TBL] [Abstract][Full Text] [Related]
23. Localization and regulation of MuSK at the neuromuscular junction.
Bowen DC; Park JS; Bodine S; Stark JL; Valenzuela DM; Stitt TN; Yancopoulos GD; Lindsay RM; Glass DJ; DiStefano PS
Dev Biol; 1998 Jul; 199(2):309-19. PubMed ID: 9698449
[TBL] [Abstract][Full Text] [Related]
24. MuSk function during health and disease.
Herbst R
Neurosci Lett; 2020 Jan; 716():134676. PubMed ID: 31811897
[TBL] [Abstract][Full Text] [Related]
25. A novel pathway for MuSK to induce key genes in neuromuscular synapse formation.
Lacazette E; Le Calvez S; Gajendran N; Brenner HR
J Cell Biol; 2003 May; 161(4):727-36. PubMed ID: 12756238
[TBL] [Abstract][Full Text] [Related]
26. Macrophage-Derived Vascular Endothelial Growth Factor-A Is Integral to Neuromuscular Junction Reinnervation after Nerve Injury.
Lu CY; Santosa KB; Jablonka-Shariff A; Vannucci B; Fuchs A; Turnbull I; Pan D; Wood MD; Snyder-Warwick AK
J Neurosci; 2020 Dec; 40(50):9602-9616. PubMed ID: 33158964
[TBL] [Abstract][Full Text] [Related]
27. MuSK signaling at the neuromuscular junction.
Wang Q; Zhang B; Xiong WC; Mei L
J Mol Neurosci; 2006; 30(1-2):223-6. PubMed ID: 17192681
[TBL] [Abstract][Full Text] [Related]
28. Implication of geranylgeranyltransferase I in synapse formation.
Luo ZG; Je HS; Wang Q; Yang F; Dobbins GC; Yang ZH; Xiong WC; Lu B; Mei L
Neuron; 2003 Nov; 40(4):703-17. PubMed ID: 14622576
[TBL] [Abstract][Full Text] [Related]
29. Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice.
Lin S; Maj M; Bezakova G; Magyar JP; Brenner HR; Ruegg MA
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11406-11. PubMed ID: 18685098
[TBL] [Abstract][Full Text] [Related]
30. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
[TBL] [Abstract][Full Text] [Related]
31. A link between agrin signalling and Ca
Delers P; Sapaly D; Salman B; De Waard S; De Waard M; Lefebvre S
Sci Rep; 2022 Nov; 12(1):18960. PubMed ID: 36347955
[TBL] [Abstract][Full Text] [Related]
32. Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK).
Zhang W; Coldefy AS; Hubbard SR; Burden SJ
J Biol Chem; 2011 Nov; 286(47):40624-30. PubMed ID: 21969364
[TBL] [Abstract][Full Text] [Related]
33. Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy.
Hui T; Jing H; Zhou T; Chen P; Liu Z; Dong X; Yan M; Ren D; Zou S; Wang S; Fei E; Hong D; Lai X
Hum Mol Genet; 2021 Aug; 30(17):1579-1590. PubMed ID: 33987657
[TBL] [Abstract][Full Text] [Related]
34. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic Activity of the Scaffold Protein Rapsyn for Synapse Formation.
Li L; Cao Y; Wu H; Ye X; Zhu Z; Xing G; Shen C; Barik A; Zhang B; Xie X; Zhi W; Gan L; Su H; Xiong WC; Mei L
Neuron; 2016 Dec; 92(5):1007-1019. PubMed ID: 27839998
[TBL] [Abstract][Full Text] [Related]
36. Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia.
Webster RG; Vanhaesebrouck AE; Maxwell SE; Cossins JA; Liu W; Ueta R; Yamanashi Y; Beeson DMW
Hum Mol Genet; 2020 Aug; 29(14):2325-2336. PubMed ID: 32543656
[TBL] [Abstract][Full Text] [Related]
37. Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury.
Pratt SJP; Shah SB; Ward CW; Kerr JP; Stains JP; Lovering RM
Cell Mol Life Sci; 2015 Jan; 72(1):153-64. PubMed ID: 24947322
[TBL] [Abstract][Full Text] [Related]
38. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
Kim JK; Caine C; Awano T; Herbst R; Monani UR
Hum Mol Genet; 2017 Jul; 26(13):2377-2385. PubMed ID: 28379354
[TBL] [Abstract][Full Text] [Related]
39. R-spondin 2 promotes acetylcholine receptor clustering at the neuromuscular junction via Lgr5.
Nakashima H; Ohkawara B; Ishigaki S; Fukudome T; Ito K; Tsushima M; Konishi H; Okuno T; Yoshimura T; Ito M; Masuda A; Sobue G; Kiyama H; Ishiguro N; Ohno K
Sci Rep; 2016 Jun; 6():28512. PubMed ID: 27328992
[TBL] [Abstract][Full Text] [Related]
40. Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis.
Yu Z; Zhang M; Jing H; Chen P; Cao R; Pan J; Luo B; Yu Y; Quarles BM; Xiong W; Rivner MH; Mei L
Neurology; 2021 Sep; 97(10):e975-e987. PubMed ID: 34233932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
